<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03899389</url>
  </required_header>
  <id_info>
    <org_study_id>DSRiK/10/2018</org_study_id>
    <nct_id>NCT03899389</nct_id>
  </id_info>
  <brief_title>Plasma TMAO (Trimethylamine N-oxide) as a Predictive Marker in Coronary Disease Patients</brief_title>
  <official_title>Plasma TMAO (Trimethylamine N-oxide) as a Predictive Marker in Coronary Disease Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gdansk University of Physical Education and Sport</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gdansk University of Physical Education and Sport</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of the current research project is to determine whether the TMAO
      concentration in the blood can serve as a prognostic indicator of myocardial infarction.

      The hypothesis is that in patients with recent myocardial infarction, TMAO concentration in
      blood is higher than in patients undergoing scheduled coronarography.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To the study will be included volunteers - patients with stable angina (SA), who were
      scheduled for conventional coronary angiography, and patients with acute coronary syndrome
      (ACS) who were admitted to the hospital with chest pain and undergoing coronography surgery.
      Blood samples will be taken from volunteers once - before the coronography surgery by
      qualified medical personnel.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Actual">May 31, 2018</completion_date>
  <primary_completion_date type="Actual">May 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Trimethylamine-N-oxidec(TMAO) blood concentration</measure>
    <time_frame>Immediately before coronography.</time_frame>
    <description>TMAO concentration determined by the ultra-performance liquid-chromatography tandem mass spektrometry (UPLC-MS/MS).</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">600</enrollment>
  <condition>Coronary Disease</condition>
  <arm_group>
    <arm_group_label>Acute Coronary Syndrome (ACS)</arm_group_label>
    <description>Patients with STEMI or NSTEMI infarction, who were admitted to the hospital with chest pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stable Angina (SA)</arm_group_label>
    <description>Patients with stable angina who were scheduled for conventional coronary angiography.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group (CON)</arm_group_label>
    <description>Healthy control group responding by age and gender to examined groups.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>plasma samples collection</intervention_name>
    <description>Trimethylamine N-oxide (TMAO) concentration will be determined in plasma samples</description>
    <arm_group_label>Acute Coronary Syndrome (ACS)</arm_group_label>
    <arm_group_label>Control Group (CON)</arm_group_label>
    <arm_group_label>Stable Angina (SA)</arm_group_label>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from the Pomeranian Cardiology Centers in Wejherowo
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosed stable angina (SA) or acute coronary syndrome (ACS) and planned coronography

        Exclusion Criteria:

          -  unconscious patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert A Olek, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Physical Education and Sport in Gdansk</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Physical Education and Sport</name>
      <address>
        <city>Gdansk</city>
        <state>Pomorskie</state>
        <zip>80-336</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 1, 2019</study_first_submitted>
  <study_first_submitted_qc>April 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2019</study_first_posted>
  <last_update_submitted>April 2, 2019</last_update_submitted>
  <last_update_submitted_qc>April 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gdansk University of Physical Education and Sport</investigator_affiliation>
    <investigator_full_name>Robert Olek</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>trimethylamine-N-oxide</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

